Nakatsu, Japan

Toshihiko Mukai

This inventor holds 1 USPTO granted patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihiko Mukai. Retrieved from https://idiyas.com/inventor/toshihiko-mukai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Toshihiko Mukai

Introduction

Toshihiko Mukai is a notable inventor based in Nakatsu, Japan. He has made significant contributions to the field of chemistry, particularly in the development of antifouling agents. His work is characterized by a focus on creating compounds that are effective yet exhibit low toxicity to mammals.

Latest Patents

Mukai holds a patent for "Certain salicylanilides," which includes salicylanilides of a specific formula. These compounds are designed to serve as antifouling agents while maintaining very low mammalian toxicity. This innovation highlights his commitment to developing safer chemical solutions.

Career Highlights

Mukai is associated with Yoshitomi Pharmaceutical Industries, Ltd., where he applies his expertise in chemistry to advance pharmaceutical research and development. His work has contributed to the company's reputation for innovation in the pharmaceutical industry.

Collaborations

Throughout his career, Mukai has collaborated with esteemed colleagues such as Kenichi Sawatari and Satoshi Oda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of their research.

Conclusion

Toshihiko Mukai's contributions to the field of chemistry, particularly through his patent for salicylanilides, demonstrate his innovative spirit and dedication to creating safer chemical agents. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…